BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | -100.0% | 2 | -100.0% | 0.00% | – |
Q3 2022 | $29,000 | -31.0% | 19,286 | -5.8% | 0.00% | – |
Q2 2022 | $42,000 | -22.2% | 20,473 | +4.4% | 0.00% | – |
Q1 2022 | $54,000 | -75.9% | 19,611 | -57.0% | 0.00% | -100.0% |
Q4 2021 | $224,000 | +17.9% | 45,640 | +204.2% | 0.00% | 0.0% |
Q3 2021 | $190,000 | – | 15,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hawkeye Capital Management, LLC | 415,039 | $431,641 | 1.06% |
Nan Fung Group Holdings Ltd | 1,166,952 | $1,213,630 | 0.98% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,967,126 | 0.78% |
TANG CAPITAL MANAGEMENT LLC | 3,557,040 | $3,699,322 | 0.52% |
Vivo Capital, LLC | 3,871,291 | $4,026,143 | 0.44% |
Samsara BioCapital, LLC | 1,049,153 | $1,091,119 | 0.33% |
Acuitas Investments, LLC | 460,379 | $478,794 | 0.28% |
Newtyn Management, LLC | 1,020,000 | $1,060,800 | 0.26% |
Sofinnova Investments, Inc. | 2,754,437 | $2,864,614 | 0.18% |
Privium Fund Management (UK) Ltd | 116,516 | $121,177 | 0.10% |